Skip to ContentSkip to Navigation
Over ons Faculty of Science and Engineering Our Research GRIP Pharmaceutical Technology and Biopharmacy Output

2002

Requests for reprints can be addressed to:

Wouter Hinrichs

 

de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique

Int J Pharm, 249, 219-231, 2002

 

de Boer AH, Gjaltema D, Hagedoorn P, Schaller M, Witt W, Frijlink HW

Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols

Int J Pharm, 249, 233-245, 2002

 

de Boer AH, Le Brun PPH, van der Woude HG, Hagedoorn P, Heijerman HGM, Frijlink HW

Dry powder inhalation of antibiotics in cystic fibroses therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

Eur J Pharm Biopharm, 54, 17-24, 2002

 

Le Brun PPH, de Boer AH, Mannes GPM, Fraîture DMI, Brimicombe RW, Touw DJ, Vinks AA, Frijlink HW, Heijerman HGM

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 2: inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients

Eur J Pharm Biopharm, 54, 25-32, 2002

 

Le Brun PPH, de Koning JP, de Boer AH, Frijlink HW, Heijerman HGM

Dry powder inhalers

J Cystic Fibrosis I, S5-S34, p. S27

 

Dickhoff BHJ, Ellison MJH, de Boer AH, Frijlink HW

The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation

Eur J Pharm Biopharm, 54, 245-248, 2002

 

van Doorne H, Boom FA

Plan van aanpak voor product en proces

PW, 137 (20), 726-731, 2002

 

Eissens AC, Bolhuis GK, Hinrichs WLJ, Frijlink HW

Inulin as filler-binder for tablets prepared by direct compression

Eur J Pharm Sci, 15, 31-38, 2002

 

Eriksson HJC, Hinrichs WLJ, van Veen B, Somsen GW, de Jong GJ, Frijlink HW

Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase

Int J Pharm, 249, 59-70, 2002

 

Frijlink HW, Hagedoorn P, Gjaltema D, Goede J, de Boer AH

An air classifier principle for effective de-agglomeration of inhalation powders

Proceedings Respiratory Drug Delivery VIII, Vol II, 451-453, 2002

 

Fyrnys B, Mueller S, de Boer AH, Wolf-Heuss E

Performace characteristics of the NovolizerTM with respect to the draft guidance for industry for metered dose inhaler and dry powder inhaler drug products

Proceedings Respiratory Drug Delivery VIII, Vol II, 603-606, 2002

 

de Koning JP, van der Mark TW, Coenegracht PMJ, Tromp TFJ, Frijlink HW

Effect of an external resistance to airflow on the inspiratory flow curve

Int J Pharm, 234, 257-266, 2002

 

Kuipers ME, Heegsma J, Bakker HI, Meijer DKF, Swart PJ, Frijlink HW, Eissens AC, de Vries-Hospers HG, van den Berg JJM

Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis

Drug Delivery, 9, 31-38, 2002

 

van Santen E, Barends DM, Frijlink HW

Breaking of scored tablets: a review

Eur J Pharm Biopharm, 53, 139-145, 2002

 

Stuurman-Bieze AGG, de Koning JP

Fouten, instructies, ontwikkelingen

PW, 137 (1), 33-36, 2002

 

van Veen B, van der Voort Maarschalk K, Bolhuis GK, Visser MR, Zuurman K, Frijlink HW

Pore formation in tablets compressed from binary mixtures as a result of deformation and relaxation of particles

Eur J Pharm Sci, 15, 171-177, 2002

 

van Veen B, van der Voort Maarschalk K, Bolhuis GK, Gons M, Zuurman K, Frijlink HW

The influence of particles of a minor component on the matrix strength of sodium chloride

Eur J Pharm Sci, 16, 229-235, 2002

 

Weda M, Zanen P, de Boer AH, Gjaltema D, Ajaoud A, Barends DM, Frijlink HW

Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy

Int J Pharm, 249, 247-255, 2002

 

Zijlstra GS, Hagedoorn P, Hinrichs WLJ, de Boer AH, Frijlink HW

Effective powder de-agglomoration principle enables the application of classical dry powder formulation techniques for peptides in inhalation

Proceedings Respiratory Drug Delivery VIII, Vol. II, 455-457, 2002

Laatst gewijzigd:22 november 2012 16:48